Insulin Pumps Edge Injections for T1D Glycemic Control
In a real-world study of adults with type 1 diabetes (T1D) in Denmark, insulin pump therapy (IPT) reduced A1c by an average 3.6 mmol/mol (an average decrease of 0.33 percentage points) compared with multiple daily injections (MDI). IPT also associated with a marginal increase in hospitalized diabetic ketoacidosis (DKA) but had no impact on severe hypoglycemia (SH) compared with MDI. The benefit of IPT was greatest in women; older individuals; and those with higher baseline A1c levels, more diabetes complications, or also using continuous glucose monitoring.